columbus cardiology columbus ohio
January 24th, 2010
No comments
BioSante Pharmaceuticals reinitiates GVAX Prostate Cancer Vaccine development
BioSante Pharmaceuticals, Inc. today announced that development of its GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been reinitiated. Manufacturing of new GVAX Prostate is in process, regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken, and prostate cancer patients are expected to be treated in a Phase II …
Ohio State University Veterinary Hospital